Heart Disease News and Research

Latest Heart Disease News and Research

Several causes for concern regarding children's health in general practice in Britain

An editorial in this weeks BMJ highlights several causes for concern regarding children's health in general practice in Britain. Once greatly admired, the British model of general practice raises concern over the future of children's health.

27 Feb 2005

Live surgical webcast of a minimally invasive mitral valve repair procedure

NYU Medical Center's Department of Cardiothoracic Surgery will conduct a live surgical webcast on March 9th at 3 pm ET of a minimally invasive mitral valve repair procedure.

27 Feb 2005

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.

24 Feb 2005

Childhood obesity is a serious health problem in Australia

Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.

24 Feb 2005

Should screening for sleep apnea be required for all men?

According to a new study, men in their 20s need to be screened the most. That's because men aged 20 to 29 with severe sleep apnea have 10 times the risk of dying from heart related ailments than their non sleep apnea peers in the general population, and a much higher risk than older men with sleep apnea.

24 Feb 2005

Counseling smokers to quit reduced their chances of dying

Giving up smoking after a heart attack has been clearly associated with improvements in long-term patient survival, but how soon after myocardial infarction does smoking cessation begin to have positive effects?

24 Feb 2005

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.

23 Feb 2005

Taipan venom used as a new drug to treat heart failure

A venom component from the Taipan, the world’s deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.

23 Feb 2005

NICE promotes use of dual-chamber pacemakers for treating bradycardia

In new medical guidance for England and Wales published today, the National Institute for Clinical Excellence (NICE) promotes the expanded use of dual-chamber pacemakers for treating slow heart rhythms, called bradycardia, which affect an estimated 100,000 people in the UK.

23 Feb 2005

Researchers identify target for cancer drugs

For nearly a decade, scientists have been trying to fully understand a particular communication pathway inside of cells that contributes to many malignant brain and prostate cancers. While scientists have identified elements of this pathway, other key components have remained a mystery.

23 Feb 2005

Study reveals need for change in surgical procedures

IPRO has announced progress in surgical infection prevention after the Archives of Surgery published a study highlighting the need for better, more consistent practices to address infection risk factors.

22 Feb 2005

Lack of magnesium in diet linked to disease

The Gordon Research International Conference on Magnesium was held during the second week in February in Ventura, California, to discuss the research findings on the links between deficiencies in the mineral magnesium and a host of life-threatening diseases, including heart disease and arteriosclerosis.

22 Feb 2005

Pharmaceutical and biotechnology industry in the new EU countries presents considerable potential

In contrast to subdued growth in the pharmaceutical markets of the former 15-state European Union (EU), pharmaceutical markets in the 'new' EU accession markets are expanding vibrantly.

22 Feb 2005

First study to explore the use of biofeedback as a complementary treatment to asthma medication

For the estimated 20.3 million adults and 6.3 million children in the U.S. who suffer from asthma, the primary treatment is the use of medications to help reduce the underlying inflammation in the airways.

22 Feb 2005

People who live with migraine headaches show a riskier profile for cardiovascular disease

People who live with migraine headaches show a "riskier" profile for cardiovascular disease than those without migraines, according to a new study published in the February 22 issue of Neurology, the scientific journal of the American Academy of Neurology.

22 Feb 2005

Computer imaging and web-based 3D tools help surgeons predict patient outcomes

People are as different on the inside as they are on the outside, making it difficult to predict how an individual will respond to a surgical intervention without resorting to statistics and educated guesses.

22 Feb 2005

Increased risk of urinary incontinence with hormone therapy

Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.

21 Feb 2005

82 percent of women have at least one factor that puts them at risk for a future heart attack

In the second year of a Northern California-based survey conducted by Sutter Health on women and heart disease, results show that more women are aware of heart attack warning signs and the need to take action quickly.

21 Feb 2005

New clues to amyloidoses

Familial amyloid polyneuropathy (FAP), a hereditary disease characterised by abnormal deposits of insoluble protein in the organs, results from a mutation in a single gene (the transthyretin or TTR gene). Nevertheless, disease incidence and age of onset can vary significantly between patients what have always puzzled scientists.

21 Feb 2005

Beta blocker lowers blood pressure and wards off repeat heart attacks

A form of beta blocker, a drug commonly used to lower blood pressure and ward off repeat heart attacks, may provide the answer to preventing osteoporosis, said a Baylor College of Medicine researcher.

20 Feb 2005